The Wall Street Journal @WSJ

Thousands of Medicare recipients will have to wait longer to get some price relief on the expensive cancer drugs they depend on for treatment, while others might not get any reprieve at all https://t.co/h0gqhuTqPB

www.wsj.com

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

Little-known provisions lobbied by industry will cost Medicare billions in missed savings.